Lung cancer signature biomarkers: Tissue specific semantic similarity based clustering of digital differential display (DDD) data

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Srivastava, Mousami ^a   Khurana, Pankaj ^a   Sugadev, Ragumani ^a  

^a DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

biomarker; Clustering analysis; Digital Differential Display (DDD); Lung tissue cancer; Multiple bootstrap; Semantic similarity

Indexed keywords

TUMOR MARKER;

ARTICLE; CLUSTER ANALYSIS; EXPRESSED SEQUENCE TAG; GENETICS; HUMAN; LUNG TUMOR;

CLUSTER ANALYSIS; EXPRESSED SEQUENCE TAGS; HUMANS; LUNG NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84868236538     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-617     Document Type: Article

References (72)

1. Candidate gene identification approach: progress and challenges. Zhu M, Zhao S, Int J Biol Sci 2007 3 7 420 427 17998950
2. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Chen J, Bardes EE, Aronow BJ, Jegga AG, Nucleic Acids Res 2009 37 Web Server issue 305 W311 19465376
3. A guide to web tools to prioritize candidate genes. Tranchevent LC, Capdevila FB, Nitsch D, De Moor B, De Causmaecker P, Moreau Y, Brief Bioinform 2011 12 1 22 32 10.1093/bib/bbq007 21278374
4. A decade of systems biology. Chuang HY, Hofree M, Ideker T, Annu Rev Cell Dev Biol 2010 26 721 744 10.1146/annurev-cellbio-100109-104122 20604711
5. Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures. Chen J, Sam L, Huang Y, Lee Y, Li J, Liu Y, Xing HR, Lussier YA, J Biomed Inform 2010 43 3 385 396 10.1016/j.jbi.2010. 03.009 20350617
6. What does systems biology mean for biomarker discovery? Azuaje F, Expert opinion on medical diagnostics 2010 4 1 10 10.1517/17530050903468709
7. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, Bull S, Pawson T, Morris Q, Wrana JL, Nat Biotechnol 2009 27 2 199 204 10.1038/nbt.1522 19182785
8. Coordinated modular functionality and prognostic potential of a heart failure biomarker-driven interaction network. Azuaje F, Devaux Y, Wagner DR, BMC Syst Biol 2010 4 60 10.1186/1752-0509-4-60 20462429
9. GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S, Bioinformatics 2010 26 7 976 978 10.1093/bioinformatics/btq064 20179076
10. A knowledge-driven approach to cluster validity assessment. Bolshakova N, Azuaje F, Cunningham P, Bioinformatics 2005 21 10 2546 2547 10.1093/bioinformatics/bti317 15713738
11. Semantic similarity in biomedical ontologies. Pesquita C, Faria D, Falcao AO, Lord P, Couto FM, PLoS Comput Biol 2009 5 7 1000443 10.1371/journal.pcbi. 1000443 19649320
12. Integration of Gene Ontology-based Similarities for Supporting Analysis of Protein-Protein Interaction Networks. Wang H, Zheng H, Browne F, Glass DH, Azuaje F, Pattern Recognit Lett 2010 31 2073 2082 10.1016/j.patrec.2010.04.011
13. TiSGeD: a database for tissue-specific genes. Xiao SJ, Zhang C, Zou Q, Ji ZL, Bioinformatics 2010 26 9 1273 1275 10.1093/bioinformatics/btq109 20223836
14. An integrated bioinformatics analysis of mouse testis protein profiles with new understanding. Liu F, Wang H, Li J, BMB Rep 2011 44 5 347 351 10.5483/BMBRep.2011.44.5.347 21615991
15. Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Suzuki R, Shimodaira H, Bioinformatics 2006 22 12 1540 1542 10.1093/bioinformatics/btl117 16595560
16. In silico comparison of gene expression levels in ten human tumor types reveals candidate genes associated with carcinogenesis. Chen S, Zhu B, Yu L, Cytogenet Genome Res 2006 112 1-2 53 59 16276090
17. UCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction. Jang MJ, Baek SH, Kim JH, Cancer Lett 2011 302 2 128 135 10.1016/j.canlet.2011.01.006 21310527
18. Silencing of Lactotransferrin expression by methylation in prostate cancer progression. Shaheduzzaman S, Vishwanath A, Furusato B, Cullen J, Chen Y, Banez L, Nau M, Ravindranath L, Kim KH, Mohammed A, et al. Cancer Biol Ther 2007 6 7 1088 1095 10.4161/cbt.6.7.4327 17568188
19. Hypoxia-mediated up-regulation of MGr1-Ag/37LRP in gastric cancers occurs via hypoxia-inducible-factor 1-dependent mechanism and contributes to drug resistance. Liu L, Sun L, Zhang H, Li Z, Ning X, Shi Y, Guo C, Han S, Wu K, Fan D, Int J Cancer 2009 124 7 1707 1715 10.1002/ijc.24135 19123465
20. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Banerjee A, Biochem Biophys Res Commun 2002 293 1 598 601 10.1016/S0006-291X(02)00269-3 12054644
21. Actin-sequestering protein, thymosin beta-4, is a novel hypoxia responsive regulator. Moon EY, Im YS, Ryu YK, Kang JH, Clin Exp Metastasis 2010 27 8 601 609 10.1007/s10585-010-9350-z 20821256
22. Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Safgren S, Hildebrandt M, Ames M, Schaid D, Wang L, Cancer Res 2008 68 17 7050 7058 10.1158/0008-5472.CAN-08-0405 18757419
23. Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy. Goswami S, Wang W, Wyckoff JB, Condeelis JS, Cancer Res 2004 64 21 7664 7667 10.1158/0008-5472.CAN-04-2027 15520165
24. The role of copper in development of drug resistance in murine carcinoma. Majumder S, Dutta P, Choudhuri SK, Med Chem 2005 1 6 563 573 10.2174/157340605774598153 16787340
25. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy. Nesterova MV, Johnson NR, Stewart T, Abrams S, Cho-Chung YS, Clin Cancer Res 2005 11 16 5950 5955 10.1158/1078-0432.CCR-05-0624 16115938
26. Vesicular transport: the core machinery of COPI recruitment and budding. Nickel W, Brugger B, Wieland FT, J Cell Sci 2002 115 Pt 16 3235 3240 12140255
27. Intracellular trafficking pathways and drug delivery: fluorescence imaging of living and fixed cells. Watson P, Jones AT, Stephens DJ, Adv Drug Deliv Rev 2005 57 1 43 61 10.1016/j.addr.2004.05.003 15518920
28. Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Kukulj S, Jaganjac M, Boranic M, Krizanac S, Santic Z, Poljak-Blazi M, Med Oncol 2010 27 2 268 277 10.1007/s12032-009-9203-2 19308738
29. The increase in pulmonary arterial pressure caused by hypoxia depends on iron status. Smith TG, Balanos GM, Croft QP, Talbot NP, Dorrington KL, Ratcliffe PJ, Robbins PA, J Physiol 2008 586 Pt 24 5999 6005 18955380
30. Glycoproteomic analysis of human lung adenocarcinomas using glycoarrays and tandem mass spectrometry: differential expression and glycosylation patterns of vimentin and fetuin A isoforms. Rho JH, Roehrl MH, Wang JY, Protein J 2009 28 3-4 148 160 19412661
31. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma. Hamaguchi T, Iizuka N, Tsunedomi R, Hamamoto Y, Miyamoto T, Iida M, Tokuhisa Y, Sakamoto K, Takashima M, Tamesa T, et al. Int J Oncol 2008 33 4 725 731 18813785
32. Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. Falanga V, Zhou L, Yufit T, J Cell Physiol 2002 191 1 42 50 10.1002/jcp.10065 11920680
33. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Tokunaga K, Nakamura Y, Sakata K, Fujimori K, Ohkubo M, Sawada K, Sakiyama S, Cancer Res 1987 47 21 5616 5619 3664468
34. Hypoxia-associated proteins. Graven KK, Farber HW, New Horiz 1995 3 2 208 218 7583162
35. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Li R, Wang H, Bekele BN, Yin Z, Caraway NP, Katz RL, Stass SA, Jiang F, Oncogene 2006 25 18 2628 2635 10.1038/sj.onc.1209289 16369491
36. Casein kinase 1 regulates human hypoxia-inducible factor HIF-1. Kalousi A, Mylonis I, Politou AS, Chachami G, Paraskeva E, Simos G, J Cell Sci 2010 123 Pt 17 2976 2986 20699359
37. Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. Bae S-K, Kim S-R, Kim JG, Kim JY, Koo TH, Jang H-O, Yun I, Yoo M-A, Bae M-K, FEBS Lett 2006 580 4105 4113 10.1016/j.febslet.2006.06. 052 16828081
38. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Planque C, Kulasingam V, Smith CR, Reckamp K, Goodglick L, Diamandis EP, Mol Cell Proteomics 2009 8 12 2746 2758 10.1074/mcp.M900134-MCP200 19776420
39. Evolutionary conserved regulation of HIF-1beta by NF-kappaB. van Uden P, Kenneth NS, Webster R, Muller HA, Mudie S, Rocha S, PLoS Genet 2011 7 1 1001285 10.1371/journal.pgen.1001285 21298084
40. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Carrero P, Okamoto K, Coumailleau P, O'Brien S, Tanaka H, Poellinger L, Mol Cell Biol 2000 20 1 402 415 10.1128/MCB.20.1.402-415.2000 10594042
41. Regulation of hypoxia-inducible genes by ETS1 transcription factor. Salnikow K, Aprelikova O, Ivanov S, Tackett S, Kaczmarek M, Karaczyn A, Yee H, Kasprzak KS, Niederhuber J, Carcinogenesis 2008 29 8 1493 1499 10.1093/carcin/bgn088 18381358
42. Roles of coactivators in hypoxic induction of the erythropoietin gene. Wang F, Zhang R, Wu X, Hankinson O, PLoS One 2010 5 4 10002 10.1371/journal. pone.0010002 20368990
43. NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response. Wang B, Hasan MK, Alvarado E, Yuan H, Wu H, Chen WY, Oncogene 2011 30 8 907 921 10.1038/onc.2010.468 20956937
44. Transglutaminase 2 protects against ischemic insult, interacts with HIF1beta, and attenuates HIF1 signaling. Filiano AJ, Bailey CD, Tucholski J, Gundemir S, Johnson GV, FASEB J 2008 22 8 2662 2675 10.1096/fj.07-097709 18375543
45. HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin. Choi H, Chun YS, Kim TY, Park JW, Cancer Res 2010 70 24 10101 10111 10.1158/0008-5472.CAN-10-0505 21159632
46. Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract. Arvidsson Y, Andersson E, Bergström A, Andersson MK, Altiparmak G, Illerskog A-C, Ahlman H, Lamazhapova D, Nilsson O, Endocrinerelated cancer 2008 15 569 581
47. Fibronectin is distinctly downregulated in murine mammary adenocarcinoma cells with high metastatic potential. Urtreger AJ, Werbajh SE, Verrecchia F, Mauviel A, Puricelli LI, Kornblihtt AR, Bal de Kier Joffe ED, Oncol Rep 2006 16 6 1403 1410 17089068
48. Changes of fibronectin in the right and left ventricles of rats exposed to chronic normobaric hypoxia. Xu Y, Shiraishi K, Mori M, Motomiya M, Tohoku J Exp Med 1992 168 4 573 582 10.1620/tjem.168.573 1306605
49. SAG/ROC2/RBX2 is a HIF-1 target gene that promotes HIF-1 alpha ubiquitination and degradation. Tan M, Gu Q, He H, Pamarthy D, Semenza GL, Sun Y, Oncogene 2008 27 10 1404 1411 10.1038/sj.onc.1210780 17828303
50. Regulation of Cyr61/CCN1 expression by hypoxia through cooperation of c-Jun/AP-1 and HIF-1α in retinal vascular endothelial cells. You J-J, Yang C-M, Chen M-S, Yang C-H, Exp Eye Res 2010 91 825 836 10.1016/j.exer.2010.10.006 21029732
51. Evidence of a Role for Antizyme and Antizyme Inhibitor as Regulators of Human Cancer. Olsen RR, Zetter BR, Mol Cancer Res 2011 9 10 1285 1293 10.1158/1541-7786.MCR-11-0178 21849468
52. Antizyme suppression leads to an increment of the cellular redox potential and an induction of HIF-1alpha: its involvement in resistance to gamma-radiation. Kim JS, Kim TL, Cho EW, Paik SG, Chung HW, Kim IG, IUBMB Life 2008 60 6 402 409 10.1002/iub.49 18484090
53. Use of an immunoaffinity-mass spectrometry-based approach for the quantification of protein biomarkers from serum samples of lung cancer patients. Nicol GR, Han M, Kim J, Birse CE, Brand E, Nguyen A, Mesri M, FitzHugh W, Kaminker P, Moore PA, et al. Mol Cell Proteomics 2008 7 10 1974 1982 10.1074/mcp.M700476-MCP200 18388126
54. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T, J Biol Chem 2003 278 50 49751 49762 10.1074/jbc.M305820200 14519765
55. Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma. Zhang JJ, Wu HS, Wang L, Tian Y, Zhang JH, Wu HL, World J Gastroenterol 2010 16 23 2881 2888 10.3748/wjg.v16.i23.2881 20556833
56. Coordination of genetic, epigenetic, and environmental factors in lung development, injury, and repair. Warburton D, Olver BE, Chest 1997 111 6 Suppl 119S 122S 9184557
57. Epigenetic regulation of surfactant protein A gene (SP-A) expression in fetal lung reveals a critical role for Suv39h methyltransferases during development and hypoxia. Benlhabib H, Mendelson CR, Mol Cell Biol 2011 31 10 1949 1958 10.1128/MCB.01063-10 21402781
58. Permissive effects of oxygen on cyclic AMP and interleukin-1 stimulation of surfactant protein A gene expression are mediated by epigenetic mechanisms. Islam KN, Mendelson CR, Mol Cell Biol 2006 26 8 2901 2912 10.1128/MCB.26.8.2901- 2912.2006 16581766
59. Cancer gene discovery using digital differential display. Scheurle D, DeYoung MP, Binninger DM, Page H, Jahanzeb M, Narayanan R, Cancer Res 2000 60 15 4037 4043 10945605
60. Identification of discriminating biomarkers for human disease using integrative network biology. Dudley JT, Butte AJ, Pac Symp Biocomput 2009 22 27 38
61. Network based consensus gene signatures for biomarker discovery in breast cancer. Frohlich H, PLoS One 2011 6 10 25364 10.1371/journal.pone.0025364 22046239
62. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL, Am J Pathol 2000 157 2 411 421 10.1016/S0002-9440(10)64554-3 10934146
63. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P, Cancer Res 2006 66 10 5021 5028 10.1158/0008-5472.CAN-05-3365 16707423
64. Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors. Cheung W, Darfler MM, Alvarez H, Hood BL, Conrads TP, Habbe N, Krizman DB, Mollenhauer J, Feldmann G, Maitra A, Pancreatology 2008 8 6 608 616 10.1159/000161012 18849643
65. Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma. Sun D, Zhou M, Kowolik CM, Trisal V, Huang Q, Kernstine KH, Lian F, Shen B, Melanoma Res 2011 21 4 335 343 10.1097/CMR.0b013e328346b715 21566537
66. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Menke A, Philippi C, Vogelmann R, Seidel B, Lutz MP, Adler G, Wedlich D, Cancer Res 2001 61 8 3508 3517 11309315
67. Nicotinamide phosphoribosyltransferase and prostaglandin H2 synthase 2 are up-regulated in human pancreatic adenocarcinoma cells after stimulation with interleukin-1. Bauer L, Venz S, Junker H, Brandt R, Radons J, Int J Oncol 2009 35 1 97 107 19513556
68. BRE over-expression promotes growth of hepatocellular carcinoma. Chui YL, Ching AK, Chen S, Yip FP, Rowlands DK, James AE, Lee KK, Chan JY, Biochem Biophys Res Commun 2010 391 3 1522 1525 10.1016/j.bbrc.2009.12.111 20035718
69. Steroid receptor coactivator-1 upregulates integrin alpha expression to promote breast cancer cell adhesion and migration. Qin L, Chen X, Wu Y, Feng Z, He T, Wang L, Liao L, Xu J, Cancer Res 2011 71 5 1742 1751 10.1158/0008-5472. CAN-10-3453 21343398
70. Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma. Jinawath N, Vasoontara C, Jinawath A, Fang X, Zhao K, Yap KL, Guo T, Lee CS, Wang W, Balgley BM, et al. PLoS One 2010 5 6 11198 10.1371/journal.pone.0011198 20585448
71. Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract. Arvidsson Y, Andersson E, Bergstrom A, Andersson MK, Altiparmak G, Illerskog AC, Ahlman H, Lamazhapova D, Nilsson O, Endocr Relat Cancer 2008 15 2 569 581 10.1677/ERC-07-0145 18430897
72. Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival. Luo JH, Xie D, Liu MZ, Chen W, Liu YD, Wu GQ, Kung HF, Zeng YX, Guan XY, Int J Cancer 2008 122 11 2554 2561 10.1002/ijc.23399 18246597